Intralipid therapy is mainly recommended for couples who have undergone IVF or other assisted reproduction treatments without achieving a healthy pregnancy.
The addition of Intralipid may be considered in cases such as:
- Recurrent implantation failure (RIF)
- Repeated first-trimester miscarriages, particularly when no other clear cause has been identified
- Unexplained infertility, when no obvious cause is found but an immunological contribution is suspected
- Confirmed high NK cell activity or abnormal Th1/Th2 ratio
- Recurrent biochemical pregnancies
A fertility specialist will evaluate the couple’s medical history and diagnostic findings in order to determine whether the addition of Intralipid therapy may help improve implantation and support the healthy progression of pregnancy.